Company: SMNR
Filing Date: 2025-10-21
Form Type: S-1
Source: 0001193125-25-245178
Chunk: 432

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-10-21
Form: S-1
Chunk 432
---
   |     | $                |      703 |   |

See accompanying notes to financial statements F-66

SEMNUR PHARMACEUTICALS, INC. STATEMENTS OF OPERATIONS (In thousands, except for share and net loss per share amounts)

|                                                                         |     | Year Ended December 31, |        2024 |   |     |   |        2023 |   |
|:------------------------------------------------------------------------|:----|:------------------------|------------:|:--|:----|:--|------------:|:--|
| Operating expenses:                                                     |     |                         |             |   |     |   |             |   |
| Research and development                                                |     | $                       |       1,709 |   |     | $ |       1,621 |   |
| General and administrative                                              |     |                         |       2,981 |   |     |   |       1,640 |   |
| Total operating expenses                                                |     |                         |       4,690 |   |     |   |       3,261 |   |
| Loss from operations                                                    |     |                         |      (4,690 | ) |     |   |      (3,261 | ) |
| Net loss                                                                |     | $                       |      (4,690 | ) |     | $ |      (3,261 | ) |
| Net loss per share — basic and diluted                                  |     | $                       |       (0.03 | ) |     | $ |       (0.02 | ) |
| Weighted average number of shares during the period — basic and diluted |     |                         | 160,000,000 |   |     |   | 160,000,000 |   |

See accompanying notes to financial statements F-67

SEMNUR PHARMACEUTICALS, INC. STATEMENTS OF STOCKHOLDERS’ DEFICIT (In thousands, except share amounts)

|                            |     | Common Stock 
 Shares       |             |     | Amount |   |     | AdditionalPaid-inCapital |        |     | AccumulatedDeficit |          |   |     | Stockholders’Equity(Deficit) |         |   |
|:---------------------------|:----|:-------------|------------:|:----|:-------|--:|:----|:-------------------------|-------:|:----|:-------------------|:---------|:--|:----|:-----------------------------|